Implementation of Advanced Practice Nurses for Specific Patient Groups (IPAP)

July 3, 2026 updated by: Nadja Nestler, Paracelsus Medical University

Implementation of Advanced Practice Nurses for Specific Patient Groups - Scientific Supervision

Problem and Relevance Due to the complexity of caring for individuals with various health conditions and their individual needs, new care models aligned with the current state of scientific knowledge are highly relevant in nursing practice. One such model involves the deployment of Advanced Practice Nurses (APNs), who are educated at master's level and therefore possess an advanced understanding of theories and models, as well as enhanced competencies in patient care. The implementation of APNs has been associated with, among other outcomes, reduced hospital readmission rates, improved patient quality of life, enhanced quality of care and nursing services, and increased job satisfaction among nursing staff.

Objective The objective of the accompanying study is to evaluate structures, processes, and experiences related to the implementation of APN roles at Salzkammergut Hospital Vöcklabruck, part of Oberösterreichische Gesundheitsholding, within the clinical areas of urology and andrology, pulmonology, visceral surgery, and vascular surgery. The aim is to identify facilitating and hindering factors affecting APN implementation. Furthermore, recommendations for the sustainable integration of APNs into clinical practice will be developed.

Design The evaluation is planned as a mixed-methods study using a convergent parallel design.

Methods As part of the accompanying research on APN role implementation, existing structures and processes within the hospital, as well as the perspectives of APNs and members of the intra- and interprofessional healthcare team, will be examined and jointly interpreted within a convergent parallel design. Based on these findings, recommendations for sustainable APN implementation will be derived. Both qualitative data (collected through individual interviews and focus group interviews) and quantitative data (collected through standardized questionnaires and a structure-process assessment tool) will be gathered. Qualitative data will be analyzed using Kuckartz's qualitative content analysis with the support of the software MAXQDA24. Quantitative data from the standardized questionnaires will be analyzed descriptively using SPSS version 30, while data from the structure-process assessment tools will be analyzed using Microsoft Excel.

Study Overview

Study Type

Observational

Enrollment (Estimated)

125

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Upper Austria
      • Vöcklabruck, Upper Austria, Austria, 4840
        • Salzkammergut Klinikum Vöcklabruck

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

  • Registered Nurses holding a consecutive master's degree (300 ECTS credits), Junior APN
  • Senior APN (master's degree holder), responsible for mentoring and supporting the Junior APNs within the hospital setting;
  • Members of the intraprofessional team (Registered Nurses and Nursing Assistants); and
  • Members of the interprofessional team who collaborate with the APNs in the care of the respective patient populations (physicians, allied health professionals, and therapists).

Description

Inclusion Criteria:

  • Registered Nurses holding a consecutive master's degree (300 ECTS credits), Junior APN
  • Senior APN (master's degree holder), responsible for mentoring and supporting the Junior APNs within the hospital setting;
  • Members of the intraprofessional team (Registered Nurses and Nursing Assistants); and
  • Members of the interprofessional team who collaborate with the APNs in the care of the respective patient populations (physicians, allied health professionals, and therapists).

All employees at Salzkammergut Hospital Vöcklabruck

Exclusion Criteria:

  • not an employee at Salzkammergut Hospital Vöcklabruck

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
APN Implentation
Evaluation of Structures, Processes, and Intra- and Interprofessional Team Experiences in the Context of Advanced Practice Nurse (APN) Role Implementation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Structure-Process-Matrix
Time Frame: From enrollment to the end lasts 12 month
developed in-house survey of structures (resources, time allocations) and processes (requirements, consultations) regarding APN implementation
From enrollment to the end lasts 12 month

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cologne Role Development in Advanced Practice Nursing Questionnaire revised
Time Frame: at three timepoints during the implementation phase at the beginning, after 6 months and after 12 months
Identification of APN's responsibilities and role during the APN implementation process
at three timepoints during the implementation phase at the beginning, after 6 months and after 12 months
Questionnaire on the Perception of Advanced Practice Nurses - Practice Patterns and Role Perception
Time Frame: at the end of implementation phase in month 12
developed in-house survey on collaboration with APNs across 7 subcategories (direct patient care, support for departmental/institutional processes and workflows, research and evidence-based practice, education, publishing and professional leadership, perception of improvements in health care, anticipated expanded APN role in patient care) in 27 items using a 5-point Likert scale (ranging from "to a very high degree" to "not at all") nd four items using a 3-point Likert scale (ranging from "improve" to "no effect") and two open-ended statements.
at the end of implementation phase in month 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stefanie Berger, MScN, BScN, Paraceslsus Medical Private University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Tracy, M. F. & O´Grady, E. (Hrsg.). (2019): Hamric and Hanson´s advanced practice nurs-ing: an integrative approach. (6.Aufl.). St. Louis, Missouri: Elsevier.
  • Schober, M., Lehwaldt, D., Rogers, M., Steinke, M., Turale, S., Pulcini, J., Roussel, J., Stewart, D. (2020). Guidelines on advanced practice nursing. Geneva, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2026

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2027

Study Registration Dates

First Submitted

June 24, 2026

First Submitted That Met QC Criteria

July 3, 2026

First Posted (Actual)

July 9, 2026

Study Record Updates

Last Update Posted (Actual)

July 9, 2026

Last Update Submitted That Met QC Criteria

July 3, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IPAP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

only IPD used in the results publication

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Evaluate Structures, Processes, and Experiences Related to the Implementation of APN Roles

3
Subscribe